Did The World Health Organization Overreact To The Threat Of A/H1N1?
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - A year after the first cases of the A/H1N1 influenza surfaced in Mexico and the U.S., the World Health Organization is facing accusations that it overreacted to the threat and pushed too hard for a rapidly available vaccine
You may also be interested in...
China State FDA Grants Simcere Record Fast-track Approval To Market Generic Relenza
SHANGHAI - Nanjing-based Simcere announced during the Chinese New Year celebration that the company received approval from China's State FDA to manufacture and market a generic version of GlaxoSmithKline's antiviral Relenza (zanamivir)
China State FDA Grants Simcere Record Fast-track Approval To Market Generic Relenza
SHANGHAI - Nanjing-based Simcere announced during the Chinese New Year celebration that the company received approval from China's State FDA to manufacture and market a generic version of GlaxoSmithKline's antiviral Relenza (zanamivir)
Nearly Half Of Hong Kong Healthcare Workers Would Refuse Swine Flu Vaccine
HONG KONG - Healthcare workers in Hong Kong are refusing swine and avian flu vaccinations despite the city's longstanding fear of epidemics